Objectives: To study the molecular epidemiology of Acinetobacter baumannii isolates from Lithuanian hospitals with an emphasis on the characterization of plasmids and antibiotic-resistance genes and their relationship with European clones (ECs) I and II.
Introduction
Acinetobacter baumannii is an emerging nosocomial pathogen, worldwide. 1 The increased use of broad-spectrum antibiotics such as carbapenems has been followed by a dramatic surge in carbapenem resistance during the last decade, leaving very limited options to treat serious infections caused by A. baumannii. 2 Carbapenem resistance in A. baumannii is associated with successful clonal lineages named European clones (ECs) I and II, which are disseminated globally. 1 The multidrug resistance phenotype of A. baumannii strains is known to be conferred by various genetic determinants, including chromosome-borne resistance genes and their regulatory sequences, mobile insertional elements, such as insertional sequences and transposons, as well as integrons and plasmids. 3 One of the most important mechanisms of carbapenem resistance in A. baumannii is associated with carbapenem-hydrolysing class D OXA-type b-lactamases (CHDLs). 2 Four groups of OXA-type acquired carbapenemases, OXA-23, OXA-24/40, OXA-58 and OXA-143, are known in A. baumannii. 4 Recent sequencing data imply that A. baumannii plasmids might represent powerful vehicles for acquisition, transfer and, most importantly, evolution of resistance due to the genetic flexibility mediated by the elements for site-specific recombination, which, at least in part, appear to be located on such plasmids. 5, 6 Detailed characterization of the plasmids circulating among ECI and ECII lineages of multidrug-resistant A. baumannii is important to understand the extent to which plasmid-borne genetic determinants are responsible for carbapenem resistance.
We present here a molecular epidemiology study of 444 A. baumannii isolates from Lithuanian hospitals with a focus on the characteristics of the plasmids and antibiotic-resistance gene profiles and their relationship with ECI and ECII lineages. We also report the genetic structure of a new GR2-type 11 kb plasmid (pAB120) harbouring two copies of a gene encoding OXA-72 b-lactamase and conferring resistance to carbapenems and demonstrate the association of strains belonging to ECII and harbouring pAB120 with a dramatic increase in the rate of carbapenem resistance in Lithuanian hospitals since 2010.
Materials and methods

Bacterial isolates
A total of 444 A. baumannii isolates were collected from July 2010 to November 2011. Isolates were recovered from various clinical specimens (lower respiratory tract, blood, urine, wounds, other sites) of patients hospitalized in intensive care units (ICUs) and other wards (non-ICUs) of three Lithuanian regional medical centres [Lithuanian University of Health Sciences Kauno Klinikos Hospital (2000 beds), Vilnius University Emergency Hospital (830 beds) and Šiauliai Hospital (1346 beds)]. Identification of A. baumannii was performed using an automated microbiology system Phoenix TM (BD, USA) and amplified rDNA restriction analysis. 7
Antimicrobial susceptibility
Antibiotic susceptibility testing to 10 antibiotics (cefoperazone/ sulbactam, meropenem, piperacillin/tazobactam, ampicillin/sulbactam, ceftazidime, gentamicin, amikacin, ciprofloxacin, imipenem and piperacillin) was performed using the disc diffusion method and the Phoenix Automated Microbiology System (BD Phoenix TM ) and interpreted according to the CLSI. 8 Genotyping Molecular typing of isolates by PFGE-ApaI restriction analysis was undertaken according to Seifert et al. 9 with some modifications (run time was set to 20 h, switch time was 5 -30 s). Gel images were analysed using Bionumerics software with the Dice coefficient and band tolerance set at 1%. Identification of international clonal lineages (ECs I-III) was carried out by multiplex PCR according to Turton et al. 10 Genotyping by multilocus sequence typing according to the scheme of the Institut Pasteur (MLST-IP) was undertaken with the primers and conditions described on the Pasteur web site (http://www.pasteur.fr/mlst).
Identification of resistance genes by PCR
Genes coding for intrinsic b-lactamases (bla OXA-51-like and bla ADC ) and acquired genes conferring narrow-spectrum resistance to b-lactams (bla TEM-1 ) or carbapenems (acquired CHDLs bla OXA-23-like , bla OXA-24/40-like , bla OXA-58-like and bla OXA-143 , and metallo-b-lactamases bla IMP , bla VIM , bla GIM , bla SPM , bla SIM and bla NDM ), aminoglycosides (aadA1, aadA2, aadB, strA, strB, aphA1, aphA2, aphA6, aacC1, aacC2, aacC4, aacA4, armA, rmtC and rmtB), tetracyclines [tet(A) and tet(B)] or phenicols (catI, catII, catIII, catB2, catB3, catB8, cmlA, cmlB and floR), class 1 integron cassettes and genes coding for the adeABC efflux pump were detected by PCR using the primers listed in Table S1 (available as Supplementary data at JAC Online). ISAba1 linkage to bla genes was determined according to Turton et al. 11 For PCR, the bacterial DNAs were extracted using an Arrow magnetic workstation (NorDiag, Norway), according to the manufacturer's instructions.
Plasmid replicon typing
Plasmid replicons were typed using the A. baumannii PCR-based replicon typing method of Bertini et al. 12 In this method, the 27 known A. baumannii replicase (rep) genes are grouped into 19 homology groups according to their nucleotide sequence similarities.
Plasmid analysis and transformation
A. baumannii plasmids were analysed by the PFGE-S1 method essentially as described previously, 13 except that run time was set at 13 h and switch time was 0.06 -21.8 s. Plasmid DNA was extracted using a GeneJet Plasmid Miniprep Kit (Thermo Fisher Scientific) and amplified by Long PCR Enzyme Mix (Thermo Fisher Scientific) with GR-specific primers, 12 according to the manufacturer's recommendations. Amplicons were digested with HindIII, Eco47I, BsrDI, EcoRI, EcoRV, PstI, DraIII and Eco57I restriction endonucleases (Thermo Fisher Scientific) and analysed on 1%-2% agarose gels. Restriction profiles were compared in silico with fully and partially sequenced Acinetobacter plasmids at GenBank (http://www.ncbi.nlm.nih.gov/). Plasmid amplicons were purified and sequenced by a primer walking strategy. Plasmid pAB120 DNA was isolated from A. baumannii clinical isolate K60 and transformed into electrocompetent carbapenem-susceptible A. baumannii clinical isolate K53 by electroporation. Transformants were selected on Luria-Bertani (LB) agar plates with 10 mg/L imipenem. MICs of transformants and donor and recipient strains were determined by the agar dilution method on Mueller-Hinton agar (Oxoid, UK) according to the CLSI. 8 DNA sequencing and sequence analysis PCR products were gel purified using a GeneJet Gel Extraction Kit (Thermo Fisher Scientific) and submitted for DNA sequencing at the DNAsequencing centre of the Institute of Biotechnology of Vilnius University (Vilnius, Lithuania).
Statistical analysis
x 2 test or Fisher's exact test was used for the comparison of categorical variables. A P value of ,0.05 was considered to be statistically significant. Statistical analyses were performed using GraphPad Prism (GraphPad software, San Diego, CA, USA).
GenBank accession number
The sequence of plasmid pAB120 has been deposited in GenBank under the accession number JX069966.
Results
Antimicrobial susceptibility testing
Resistance to carbapenems among A. baumannii isolates was found in 43% (190/444) of isolates, being more frequent in ICUs than non-ICUs (P,0.05) in all hospitals. All carbapenemresistant isolates except five were resistant to both imipenem and meropenem. Multidrug resistance (resistance to at least three distinct classes of antibiotics) applied to 93% (411/444) of A. baumannii isolates. Approximately 95% of isolates were resistant to ciprofloxacin, piperacillin and ceftazidime (420/444, 419/444 and 420/444, respectively), 45% were resistant to Carbapenem-resistant A. baumannii carrying a plasmid with two genes encoding OXA-72 in Lithuania cefoperazone/sulbactam (202/444). Resistance to the aminoglycosides gentamicin and amikacin was 78% (345/444) and 77% (342/444), respectively.
Genotyping
The isolates were assigned to 74 pulsotypes according to PFGE-ApaI macrorestriction patterns ( Figure S1 , available as Supplementary data at JAC Online). Pulsotype Groups I -IV accounted for 89% (393/444) of isolates. Other isolates (51/444) were unique (similarity ,80%) or non-typeable. The most prevalent in all hospitals were Group I and II pulsotypes, comprising Clusters 1 and 2 (at 80% Dice similarity cut-off) ( Table 1 and Figure S1 , available as Supplementary data at JAC Online). Representative isolates from pulsotype Groups I and IV were of ST1 type and isolates from pulsotype Groups II and III were of ST2 type according to MLST-IP. Cluster 1 and 2 isolates belonged to ECI and ECII clones, respectively ( Table 1 ). Cluster 2 isolates were significantly more resistant to carbapenems, whereas their resistance to cefoperazone/sulbactam, ampicillin/sulbactam and aminoglycosides was significantly lower (P,0.01) if compared with Cluster 1 isolates. Overall, of all isolates studied, 230 (52%) and 202 (45%) belonged to ECI and ECII clones, respectively.
Antibiotic-resistance genes
The resistance-associated gene profiles of A. baumannii isolates are summarized in Table 1 . Forty-two percent of isolates (188/444) had genes coding for CHDLs being represented by bla OXA-24/40-like and bla OXA-23-like group genes. The bla OXA-24/40-like gene coded for the OXA-72 b-lactamase in all seven representative isolates selected for sequencing from different pulsotypes of Cluster 2. All isolates had genes coding for intrinsic b-lactamases (bla OXA-51-like and bla ADC ). Ninety-two percent (408/444) of bla ADC genes were linked to ISAba1. No bla OXA-51-like genes were found associated with ISAba1. Genes coding for metallo-b-lactamases were not detected.
Class I integrons with a gene cassette region had 59% (238/406) of intI1-positive (91%, 406/444) isolates. The most frequent was the 2500 bp/aacC1-orfX ′ -orfX ′′ -aadA1 integron, which was significantly associated with ECI isolates (83%, 192/230) compared with ECII isolates (1.5%, 3/202) (P,0.01).
Overall, the ECI isolates more frequently (72%, 165/230) had genes conferring a multidrug resistance profile [aacC1, aadA1, aphA1, aphA6 (aminoglycosides), catI (chloramphenicol), tet(A) (tetracycline), adeB, adeJ (efflux pump) and tem (b-lactams)], whereas in ECII isolates the gene profile strA, strB (streptomycin), tet(B) (tetracycline) and adeJ (71%, 144/202) was more common (P,0.01).
Plasmids
The rep gene homology groups and plasmids observed in A. baumannii isolates are summarized in Table 2 . ECI isolates were significantly associated with the carriage of a combination of GR2+ GR6 replicons (90%, 206/230), whereas ECII isolates most often had the GR2 replicon type (56%, 113/202) (P,0.01).
Five plasmids, present as various combinations of one to four, were found in A. baumannii isolates ( Table 2 ). The combination of 9 + 70 kb plasmids was dominant in ECI isolates (60%, 137/230) and the ECII isolates most frequently had a single 11 kb plasmid (56%, 113/202).
The carriage of a 6 kb plasmid (Table 2 ) coincided with the presence of an aadB gene (conferring resistance to gentamicin, kanamycin and tobramycin) in 54 of ECI isolates and 22 of ECII isolates, respectively (Table 1) . PCR mapping using primers listed in Table S1 (available as Supplementary data at JAC Online) has confirmed the location of aadB gene on the 6 kb plasmid pRAY, 14 which was recently reported in A. baumannii ECII isolates from Australia. 15 Novel GR2 type plasmid in carbapenem-resistant A. baumannii clinical isolates belonging to ECII In carbapenem-resistant bla OXA-24/40-like -positive ECII isolates the 11 kb plasmid was most common, found alone or in different combinations ( Table 2 ). The identity of this plasmid was further investigated by PCR-based amplification of full-length amplicons (see the Materials and methods section). PCRs produced 11 kb amplicons. The comparison of their restriction profiles in silico yielded no matches with those of the known A. baumannii plasmid DNA sequences in the National Center for Biotechnology Information database. The newly found plasmid designated pAB120, was isolated from host A. baumannii strain A60 and conferred resistance to imipenem (MIC 32 mg/L) and meropenem (MIC 32 mg/L) upon introduction into the recipient A. baumannii strain (K53), which was susceptible to both carbapenems (MIC ,4 mg/L). The carriage of bla OXA-24/40-like and rep genes was confirmed by PCR. A full-length amplicon of pAB120 was sequenced by a primer walking strategy. pAB120 was 10 879 bp in length and possessed 13 open reading frames, including two copies of a gene for OXA-24/40-like b-lactamase OXA-72, flanked by XerC/XerD-like binding sites ( Figure 1 and Table S2 , available as Supplementary data at JAC Online). pAB120 showed the highest sequence similarity to known GR2 plasmids p1ABTCDC0715, p2ABAYE, pAB0057, pABVA01 and pMMCU3 (Figure 1 ). The major differences between pAB120 and related plasmids were found within regions flanked by XerC/XerD-like sites 1 -2 and 2 -3, respectively. A module with an additional copy of the bla OXA-72 gene, surrounded by XerC/XerD-like sites 1 -2 was present in pAB120, which in plasmids p1TCDC0715, pAB0057 and p2ABAYE is replaced by a region of different composition. In addition, pAB120 had genes comprising a putative toxin -antitoxin system, flanked by XerC/XerD-like sites 2-3. The DNA module of a similar fragment was observed in unrelated Acinetobacter plasmids pAB1, pMAC, p3ABAYE and pAV2 (Figure 1) .
Screening of A. baumannii isolates for the presence of pAB120 plasmid by two multiplex PCR using primer pairs targeting the unique sequences in plasmid DNA including both plasmid-borne bla OXA-72 genes (Table S1, available as Supplementary data at JAC Online), showed that pAB120 was present in 95% (165/174) of bla OXA-24/40-like -positive ECII isolates belonging to Cluster 2 from all hospitals. Povilonis et al. 
Discussion
The proportion of carbapenem-resistant A. baumannii in Lithuanian tertiary-care medical centres has increased dramatically. The rise in the rate of carbapenem-resistant bacteria in the country's hospitals has occurred mainly during the years 2010-11, increasing from 4% reported in 2008-09 to 43% in 2011 (data not shown). The most widespread A. baumannii genotypes found in Lithuanian hospitals comprised PFGE genotype Clusters 1 and 2, whose isolates belonged to the international clonal lineages ECI and ECII, respectively. Isolates of ECI and ECII clonal lineages displayed characteristic resistance gene profiles and plasmid content, showing that different resistance mechanisms are developed by A. baumannii belonging to these clones. The most prevalent carbapenemase producers, found in all hospitals, were ECII isolates belonging to Cluster 2 and carrying two copies of the gene for acquired OXA-72 carbapenemase on the newly observed plasmid pAB120. Our study shows that clonal spread of OXA-72producing ECII strains was largely responsible for the dramatic increase in the incidence of carbapenem-resistant A. baumannii in the country's tertiary-care hospitals. In contrast to OXA-23, which is the most commonly acquired carbapenemase in A. baumannii worldwide, 1 OXA-72-producing isolates have been reported in only a limited number of countries including Brazil, Colombia, Taiwan, the USA, France and Croatia. 16 -21 More recently, a study of A. baumannii from Poland has reported sporadic isolates with chromosome-borne OXA-72. 22 Of particular interest is the ubiquitous novel GR2 group plasmid pAB120 found in ECII isolates. In addition to two copies of the gene for OXA-72 b-lactamase, flanked by XerC/XerD-like sites, pAB120 also carried genes for two putative toxin -antitoxin systems, which could be involved in plasmid maintenance. Recent studies have demonstrated the presence of different DNA modules of various intervening regions flanked by XerC/XerD binding sites in A. baumannii plasmids. 6,20,23 -25 XerC and XerD recombinases are involved in a separation of plasmid and chromosome dimers during replication and cell division by recognition of dif-like binding sites. 26 According to the recent observations, Xer proteins might act as a site-specific recombination system responsible for mobilization of bla OXA-24/40-like genes among Acinetobacter species. 21, 23 Indeed, plasmids with the bla OXA-24/40-like gene integrated into different locations flanked by XerC/XerD-like binding sites were recently reported in A. baumannii strains from Spain, Italy, Portugal, the USA and Colombia. 6,19,20,23 -25 To the best of our knowledge, pAB120 is the first plasmid harbouring two copies of the gene coding for OXA-72 b-lactamase that is observed in carbapenem-resistant A. baumannii isolates. The expression of two bla OXA-72 gene copies in A. baumannii carrying pAB120 was two or three times lower if compared with the same A. baumannii strain transformed with plasmid pAC92 6 harbouring a single bla OXA-40 gene copy as determined by RT-PCR (data not shown), most probably due to the mutation (an A to G change, one position downstream from a putative 210 box) observed in the promoter region of bla OXA-72 genes in pAB120 ( Figure S2 , available as Supplementary data at JAC Online). 
Povilonis et al.
Very similar positions of XerC/XerD recognition sites downstream from the replicase coding genes in pAB120 and in plasmids pAB0057/p1ABTCDC0715 let us presume that an ancestral repAci1/repAci2-type plasmid, harbouring recombination targets of XerC/XerD, could be employed as a platform for a XerC/XerD-mediated recombination system to form plasmids with distinct genetic arrangement. The presence of a large region with another copy of the bla OXA-72 gene surrounded by XerC/XerD recognition sites and homologous to its counterparts in plasmids pABVA01 and pMMCU3, suggests that large common genetic platforms flanked by XerC/XerD recognition sites might participate in the dissemination of bla OXA-24/40-like genes and in the rearrangement of plasmids in Acinetobacter spp. Moreover, the presence of another region in pAB120, harbouring the putative toxin-antitoxin system, bracketed with XerC/XerD-like sites and showing the highest identity to the regions in unrelated plasmids pAB1 and pAV2, suggests that different plasmids may exchange not only CHDL coding genes but also other components within a limited region between the two closest XerC/XerD binding sites. The structure of pAB120 consisting of the two DNA modules (with bla OXA-72 gene each) may be a result of several recombination events, mediated by XerC/XerD recombinases. The XerC/XerD system seems not to be a unique site-specific recombination mechanism involved in the acquisition of CHDLs in plasmids of A. baumannii. Several studies have reported A. baumannii plasmids associated with repAci1 and repAci2 genes, carrying a locus with bla OXA-58 gene bracketed by two copies of the Re27 sequence. 27 -29 Re27 and XerC/XerD-like binding sites reveal very high degrees of sequence identity, which further supports their involvement in the acquisition of CHDLs by site-specific recombination.
